Fairscale Capital LLC Cuts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Fairscale Capital LLC lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,544 shares of the healthcare conglomerate’s stock after selling 60 shares during the period. UnitedHealth Group comprises approximately 1.3% of Fairscale Capital LLC’s holdings, making the stock its 14th largest holding. Fairscale Capital LLC’s holdings in UnitedHealth Group were worth $1,487,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Kathleen S. Wright Associates Inc. purchased a new position in UnitedHealth Group in the third quarter valued at about $27,000. Macroview Investment Management LLC grew its stake in shares of UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group during the second quarter worth about $31,000. Global Wealth Strategies & Associates lifted its holdings in shares of UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC lifted its holdings in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.1 %

Shares of UNH opened at $590.87 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a 50 day moving average price of $582.63 and a 200 day moving average price of $552.95. The stock has a market capitalization of $543.77 billion, a price-to-earnings ratio of 38.49, a PEG ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same period in the prior year, the business earned $6.56 EPS. The firm’s quarterly revenue was up 9.2% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on UNH shares. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday. Royal Bank of Canada decreased their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. KeyCorp initiated coverage on UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. HSBC downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Truist Financial restated a “buy” rating and issued a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.